Exter Neil
CIK 0001620014
Director10% Owner
Filings
6
Latest Sep 24, 2025
Issuers covered
4
Showing
6 of 6
Page 1
Track record
1 of 1 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 1 | 0% | -19.3% | -19.3% | -19.3% | -19.3% |
| 90 days | 1 | 0% | -2.0% | -2.0% | -2.0% | -2.0% |
| 180 days | 1 | 0% | -24.0% | -24.0% | -24.0% | -24.0% |
| 365 days | 1 | 0% | -26.6% | -26.6% | -26.6% | -26.6% |
Issuers
Companies where Exter Neil has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| MAZE | Maze Therapeutics, Inc. | 2 | Sep 24, 2025 |
| RVMD | Revolution Medicines, Inc. | 2 | Jun 17, 2022 |
| DBTX | Decibel Therapeutics, Inc. | 1 | Jun 21, 2022 |
| PLRX | Pliant Therapeutics, Inc. | 1 | Jun 21, 2022 |
All filings
6 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|